Company intelligence / Profile preview

JPMorgan Partners

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

J.P. Morgan Life Sciences Private Capital is an investment firm that launched a $500M+ inaugural fund in 2024 to invest in private biotech companies across various stages, modalities, and geographies. It focuses on company creation, Seed/Series A, and Series B to pre-IPO investments.

Industry: Investors

Partnerships

JPMorgan Chase & Co.Institutional allocatorsStrategic corporate partnersFamily officesHigh net worth individuals

Beyond the preview

Go deeper on JPMorgan Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JPMorgan Partners.

Explore the full profile